The incidence and impact of anosmia on daily life after COVID-19 infection

References

1. 1.↵
   1. Gao Z,
   2. Xu Y,
   3. Sun C,
   4. Wang X,
   5. Guo Y,
   6. Qiu S, et al.

   A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 2020; 54: 12–16.

   OpenUrl
2. 2.↵
   1. Tong JY,
   2. Wong A,
   3. Zhu D,
   4. Fastenberg JH,
   5. Tham T.

   The prevalence of olfactory and gustatory dysfunction in COVID-19 Patients: A systematic review and meta-analysis. Otolaryngol Head Neck Surg 2020; 163: 3–11.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Umakanthan S,
   2. Sahu P,
   3. Ranade AV,
   4. Bukelo MM,
   5. Rao JS,
   6. Abrahao-machado LF, et al.

   Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020; 96: 753–758.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Matta S,
   2. Chopra KK,
   3. Arora VK.

   Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc 2020; 67: S167–S172.

   OpenUrl
5. 5.↵
   1. Sedaghat AR,
   2. Gengler I,
   3. Speth MM.

   Olfactory dysfunction: A highly prevalent symptom of COVID-19 with public health significance. Otolaryngol Head Neck Surg 2020; 163: 12–15.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Nanzer AM,
   2. Chambers ES,
   3. Ryanna K,
   4. Richards DF,
   5. Black C,
   6. Timms PM, et al.

   Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol 2013; 132: 297–304.e3.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Meng X,
   2. Deng Y,
   3. Dai Z,
   4. Meng Z.

   COVID-19 and anosmia: A review based on up-to-date knowledge T. Am J Otolaryngol 2020; 41: 102581.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Dominguez I,
   2. Lechuga R,
   3. Izquierdo-Dominguez A,
   4. Rojas-Lechuga M,
   5. Mullol J,
   6. Alobid I.

   COVID-19 and olfactory dysfunction. J Investig Allergol Clin Immunol 2020; 30.
9. 9.↵
   1. Elwany S,
   2. Atef A,
   3. Ibrahim AA,
   4. Ismail AS,
   5. Hussein WK,
   6. Youssef AS, et al.

   Arabic translation and validation of SNOT-22. Egypt J Otolaryngol 2017; 33: 611–615.

   OpenUrl
10. 10.↵
    1. Rudmik L,
    2. Soler ZM,
    3. Mace JC,
    4. DeConde AS,
    5. Schlosser RJ,
    6. Smith TL.

    Using preoperative SNOT-22 score to inform patient decision for Endoscopic sinus surgery. Laryngoscope 2015; 125: 1517–1522.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Mattos JL,
    2. Edwards C,
    3. Schlosser RJ,
    4. Hyer M,
    5. Mace JC,
    6. Smith TL, et al.

    A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol 2019; 9: 1144–1150.

    OpenUrlCrossRef
12. 12.↵
    1. Alsayid H,
    2. Alnakhli S,
    3. Marzouki HZ.

    Arabic translation and validation of olfactory-specific quality of life assessment questionnaire. Cureus 2021; 13: e16000.

    OpenUrl
13. 13.↵
    1. Levy JM,
    2. Mace JC,
    3. Rudmik L,
    4. Soler ZM,
    5. Smith TL.

    Low SNOT-22 scores in chronic rhinosinusitis: Why do patients seek treatment? Laryngoscope 2017; 127: 22–28.

    OpenUrl
14. 14.↵
    1. Elkholi SMA,
    2. Abdelwahab MK,
    3. Abdelhafeez M.

    Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients. Eur Arch Otorhinolaryngol 2021; 125: 1517–1522.

    OpenUrl
15. 15.↵
    1. AlShakhs A,
    2. Almomen A,
    3. AlYaeesh I,
    4. AlOmairin A,
    5. AlMutairi AA,
    6. Alammar Z, et al.

    The Association of Smell and Taste Dysfunction with COVID19, And Their Functional Impacts. Indian J Otolaryngol Head Neck Surg 2021: 1–6.
16. 16.↵
    1. Plonka A

    1. Chirio D

    1. Demonchy É

    1. Vandersteen C,
    2. Payne M,
    3. Dumas L-émilie

    , Plonka A, Chirio D, Demonchy É, et al. Persistent olfactory complaints after COVID-19: a new interpretation of the psychophysical olfactory scores*. Rhinol online 2021; 50: 11–3.

    OpenUrl
17. 17.↵
    1. Rombaux P,
    2. Huart C,
    3. Collet S,
    4. Eloy P,
    5. Negoias S,
    6. Hummel T.

    Presence of olfactory event-related potentials predicts recovery in patients with olfactory loss following upper respiratory tract infection. Laryngoscope 2010; 120: 2115–2118.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Reden J,
    2. Mueller A,
    3. Mueller C,
    4. Konstantinidis I,
    5. Frasnelli J,
    6. Landis BN, et al.

    Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg 2006; 132: 265–269.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Perry BF,
    2. Kountakis SE.

    Subjective improvement of olfactory function after endoscopic sinus surgery for chronic rhinosinusitis. Am J Otolaryngol 2003; 24: 366–369.

    OpenUrlCrossRefPubMed
20. 20.
    1. Welge-Lüssen A,
    2. Wolfensberger M.

    Olfactory disorders following upper respiratory tract infections definition of postviral olfactory disorders. Adv Otorhinolaryngol 2006; 63: 125–132.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Sánchez-Vallecillo MV,
    2. Fraire ME,
    3. Baena-Cagnani C,
    4. Zernotti ME.

    Olfactory dysfunction in patients with chronic rhinosinusitis. Int J Otolaryngol 2012; 2012: 1–5.

    OpenUrl
22. 22.↵
    1. Soler ZM,
    2. Kohli P,
    3. Storck KA,
    4. Schlosser RJ.

    Olfactory impairment in chronic rhinosinusitis using threshold, discrimination, and identification scores. Chem Senses 2016; 41: 713–719.

    OpenUrlCrossRefPubMed